Levi Strauss stock falls
Telsey Advisory Group analyst Dana Telsey reiterated the Outperform rating on Levi Strauss & Co (NYSE:LEVI), with an ...
Levi Strauss & Co. faces challenges with disappointing revenue and declining Dockers sales. Learn more about LEVI stock and ...
Levi's maintains a bullish outlook with a price target of $23. Constellation Brands ( STZ) are trading lower today after the ...
J.P. Morgan analyst Matthew Boss maintained a Hold rating on Levi Strauss & Co (LEVI – Research Report) yesterday and set a price ...
Levi Strauss & Co (LEVI) reports strong brand growth and profitability, while exploring strategic alternatives for Dockers ...
Hims & Hers Health shares are slipping more than 8% after the Food and Drug Administration said there were no longer shortages of Eli Lilly’s obesity and diabetes drugs Zepbound and Mounjaro.
Bank of America Securities analyst Christopher Nardone reiterated a Hold rating on Levi Strauss & Co (LEVI – Research Report) today ...